|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.76 USD | +1.99% |
|
+3.89% | +242.69% |
| Market Cap | 3.61B 3.16B 2.91B 2.68B 5.07B 348B 5.16B 34.78B 13.65B 170B 13.56B 13.27B 586B | P/E 2026 * |
-29.8x | P/E 2027 * | -21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.33B 2.91B 2.69B 2.47B 4.68B 320B 4.76B 32.07B 12.58B 157B 12.51B 12.23B 540B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 467,134x |
| Free-Float |
93.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Enliven Therapeutics, Inc.
| 1 day | +2.03% | ||
| 1 week | +3.89% | ||
| Current month | +3.99% | ||
| 1 month | +24.59% | ||
| 3 months | +20.08% | ||
| 6 months | +109.67% | ||
| Current year | +242.69% |
| 1 week | 49.51 |  | 52.95 |
| 1 month | 40.95 | | 52.95 |
| Current year | 14.78 | | 52.95 |
| 1 year | 14.78 | | 52.95 |
| 3 years | 9.8 | | 52.95 |
| 5 years | 9.8 | | 52.95 |
| 10 years | 9.8 | | 52.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anish Patel
COO | Chief Operating Officer | 46 | 22/02/2023 |
Richard Fair
CEO | Chief Executive Officer | 57 | 10/12/2025 |
| Chief Tech/Sci/R&D Officer | 61 | 22/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Derynck
BRD | Director/Board Member | 63 | 22/02/2023 |
Rishi Gupta
BRD | Director/Board Member | 48 | 22/02/2023 |
Rahul Ballal
BRD | Director/Board Member | 48 | 22/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-05 | Sell | Director | -10,000 | 0.0140% | ||
| 06-21 | OrbiMed Advisors Private Equity
| Sell | Company | -860,123 | 1.4122% | |
| 06-16 | Fiscal year | Chief Technology Officer | 15,000 | 0.0246% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.99% | +3.89% | +143.76% | +183.74% | 3.61B | |
| -1.39% | -6.15% | +56.05% | +71.53% | 54.49B | |
| +3.13% | +11.16% | +67.30% | +94.35% | 55.93B | |
| -0.42% | -5.83% | +6.68% | +430.14% | 23.87B | |
| +1.19% | -2.10% | -17.25% | -14.59% | 22.86B | |
| +3.51% | +7.50% | +47.81% | -3.33% | 20B | |
| +1.94% | +0.21% | +39.31% | -29.41% | 17.48B | |
| +10.00% | -2.06% | +210.10% | +370.99% | 15.39B | |
| +7.69% | +4.38% | +56.51% | +712.88% | 15.19B | |
| -0.31% | -0.65% | +26.52% | +190.49% | 14.02B | |
| Average | +2.73% | +0.46% | +63.68% | +200.68% | 24.28B | |
| Weighted average by Cap. | +2.03% | +0.49% | +54.40% | +158.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 7.14K 6.24K 5.76K 5.29K 10.03K 687K 10.2K 68.75K 26.97K 336K 26.81K 26.23K 1.16M |
| Net income | -115M -101M -93.05M -85.54M -162M -11.1B -165M -1.11B -436M -5.43B -433M -424M -18.7B | -164M -144M -133M -122M -231M -15.81B -235M -1.58B -621M -7.73B -617M -603M -26.63B |
| Net Debt | -281M -246M -227M -209M -395M -27.07B -402M -2.71B -1.06B -13.23B -1.06B -1.03B -45.6B | -277M -242M -223M -205M -389M -26.62B -395M -2.66B -1.05B -13.01B -1.04B -1.02B -44.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | US$52.81 | +2.09% | 269,085 |
| 14/07/26 | US$51.73 | +1.69% | 749,919 |
| 13/07/26 | US$50.87 | -0.43% | 600,115 |
| 10/07/26 | US$51.09 | -2.09% | 623,681 |
| 09/07/26 | US$52.18 | +2.72% | 998,574 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ELVN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition